Genesys Capital
Venture capitalSeed–Series B
Investment thesis
Genesys Capital invests in high-growth biotechnology, pharmaceuticals, and medical technology companies. The firm leverages decades of experience and relationships with leading North American research institutions to gain early access to breakthrough scientific discoveries. Working closely with scientific founders, Genesys aims to transform emerging bioscience opportunities into commercially successful enterprises that advance medicine and address unmet medical needs.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 1 of 14 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
Investments · 14 tracked
founders shown can be your intro pathFusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Frequently asked questions
- What stage does Genesys Capital invest at?
- Genesys Capital invests at the Seed, Series A, Series B stages.
- What sectors does Genesys Capital focus on?
- Genesys Capital focuses on Biotech, Medical Devices.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.